Nothing is going wrong, but one of its peers just hit a serious snag.If you can do the mental work to separate your sentiment about a stock from its recent price action, buying the dip in a recently dented winner can be a profitable investing strategy. Of course, it's key that you determine whether a business is experiencing a temporary setback or a more durable downturn before making the decision to buy. That can make the difference between buying the dip and making more money later, and buying the dip onl ...

文章核心观点 - 该公司在2023年11月29日至2024年3月22日期间的证券交易中存在虚假陈述和重大遗漏 [1][5] - 公司误导性地夸大了其获得美国林业局2024年火灾季节续约合同的可能性,因为其消防阻燃剂存在安全隐患 [5] - 公司对其消防阻燃剂安全性的测试结果存在严重夸大 [5] - 上述行为导致公司的业务、运营和前景陈述存在重大虚假和误导性 [5] 公司相关 - 公司名称为Compass Minerals International, Inc. [1] - 公司股票代码为NYSE: CMP [1] - 公司主要从事消防阻燃剂业务 [5] - 公司与美国林业局存在合作关系,提供专有的氯化镁基消防阻燃剂 [5] 投资者权益 - 投资者可以在2024年6月24日之前加入集体诉讼 [1][3] - 投资者无需支付任何费用即可获得赔偿,采用或有费用安排 [2] - 投资者可以选择合适的律师代表自己参与诉讼 [7] - 即使不担任首席原告,投资者也可以分享潜在的赔付 [7]

NEW YORK, June 07, 2024 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP notifies investors in Compass Minerals International, Inc. ("Compass Minerals" or the "Company") (NYSE: CMP) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Compass Minerals investors who were adversely affected by alleged securities fraud between November 29, 2023 and March 22, 2024. Follow the link below to get more information and be contacted by a member of our team: https://zlk.com ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, June 06, 2024 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Compass Minerals International, Inc. ("Compass Minerals" or the "Company") (NYSE: CMP) investors that a class action has been filed on behalf of investors. Compass Minerals investors that lost money on their investment are encouraged to contact Lesley Portnoy, Esq. Investors who purchased and/or sold shares between November 29, 2023 and March 2 ...

NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Pomerantz LLP announces that a class action lawsuit has been filed against Compass Minerals International, Inc. (“Compass” or the “Company”) (NYSE: CMP).   Such investors are advised to contact Danielle Peyton at newaction@pomlaw.com or 646-581-9980, (or 888.4-POMLAW), toll-free, Ext. 7980. Those who inquire by e-mail are encouraged to include their mailing address, telephone number, and the number of shares purchased. The class action concerns whether Compass and ...

NEW YORK, June 05, 2024 (GLOBE NEWSWIRE) -- Faruqi & Faruqi, LLP, a leading national securities law firm, is investigating potential claims against Compass Minerals International, Inc. (“Compass Minerals” or the “Company”) (NYSE: CMP) and reminds investors of the June 24, 2024 deadline to seek the role of lead plaintiff in a federal securities class action that has been filed against the Company. Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses ...

NEW YORK, June 5, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Compass Minerals International, Inc. (NYSE: CMP).Shareholders who purchased shares of CMP during the class period listed are encouraged to contact the firm regarding possible lead plaintiff appointment. Appointment as lead plaintiff is not required to partake in any recovery.CONTACT US HERE:https://securitiesclasslaw.com/securities/compass-minerals-loss-submission-form/?id=82727&from=4CLASS PERIOD: Novem ...

Vessel Brand Unveils the Second-Generation Compass Rise - The Next Evolution in Functionality and EleganceMay 30, 2024 9:20 AM EDT | Source: Flora Growth Corp.Fort Lauderdale, Florida--(Newsfile Corp. - May 30, 2024) - Flora Growth Corp. (NASDAQ: FLGC) ("Flora" or the "Company")'s Vessel Brand ("Vessel"), renowned for its design and precision craftsmanship, proudly announces the release of Compass Rise. Built for the discerning connoisseur, Compass Rise embodies sophistication while delivering ...

BOSTON, May 30, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinicalstage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that the Company will participate in a fireside chat at the Jefferies Global Healthcare Conference taking place in New York City, NY June 5 – 6, 2024. Fireside Chat details Date: Wednesday, June 5, 2024 Time: 1:00 – 1:25 PM ET Webcast Link: https://wsw.com/jefferiesw ...

BOSTON, May 28, 2024 (GLOBE NEWSWIRE) -- Compass Therapeutics, Inc. (Nasdaq: CMPX), a clinicalstage, oncology-focused biopharmaceutical company developing proprietary antibody-based therapeutics to treat multiple human diseases, today announced that its Board of Directors has appointed Thomas Schuetz, M.D., Ph.D., President of Research and Development and Vice Chair of the Board of Directors of the Company, as President and Chief Executive Officer of the Company, effective May 28, 2024. Vered Bisker-Leib, P ...